Grants per year
Personal profile
Research Interests
Dr Nardone’s research focuses on pharmacovigilance and previously undetected and/or undefined drug adverse events and co-morbidities utilizing real world data related to dermatology. As a senior researcher with RADAR (Research on Adverse Drug events And Report) and through the detection of safety signals from “big data “, Dr Nardone effectively conducts data mining that utilizes various data sources, including the FDA and other national database as well as electronic health records, to report new associations that reflect serious adverse events and comorbidities relatable to dermatology practice. Another important dimension to her research focus is the use of state of the art non-invasive instrumentation to augment the diagnostic capabilities of the dermatologist, including, among others, dermoscopy, capillaroscopy and confocal reflectance microscopy technology.
Education/Academic qualification
PhD, University of Catania
… → 2011
MD, University of Catania
… → 2003
Fingerprint
Dive into the research topics where Beatrice Nardone is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Grants
- 1 Active
-
Determinants of transdermal drug delivery to the normal and the radiated breast
Blanco Jr, L. Z., Guitart, J., Khan, S. A., Lee, O. & Nardone, B.
2/5/19 → 1/31/24
Project: Research project
Research Output
-
Association of bullous pemphigoid and comorbid health conditions: a case–control study
Lee, S., Rastogi, S., Hsu, D. Y., Nardone, B. & Silverberg, J. I., 2020, (Accepted/In press) In: Archives of Dermatological Research.Research output: Contribution to journal › Article › peer-review
-
Bullous disorders associated with PD-1 and PD-L1 inhibitors: Pharmacovigilance analysis of the United States Food and Drug Administration Adverse Event Reporting System from the Research on Adverse Drug Events And Reports Program
Jimenez, J., Gwillim, E. C., Kosche, C., Figueiredo, A., Rauck, C., Rangel, S. M., Choi, J., West, D. P., Nardone, B. & Lacouture, M. E., Sep 2020, In: Journal of the American Academy of Dermatology. 83, 3, p. 955-957 3 p.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Cutaneous T-cell lymphoma after chronic exposure to hydrochlorothiazide: pharmacovigilance analysis from the RADAR (Research on Adverse Drug events And Reports) Program
Pease, D. R., Martinez-Escala, M. E., Jimenez, J., Guitart, J., West, D. P. & Nardone, B., 2020, (Accepted/In press) In: Journal of the European Academy of Dermatology and Venereology.Research output: Contribution to journal › Letter › peer-review
-
Risks for noncutaneous second primary malignancy in cutaneous malignant melanoma survivors: an analysis of data from the Surveillance, Epidemiology, and End Results (SEER) program
Vakharia, P. P., Kelm, R. C., Orrell, K. A., Patel, K. R., Singam, V., Ali, Y., Rastogi, S., Yousif, R., Rangel, S. M., West, D. P. & Nardone, B., Apr 1 2020, In: International Journal of Dermatology. 59, 4, p. 463-468 6 p.Research output: Contribution to journal › Article › peer-review
-
Current Advances in the Prevention, Risk, and Management of Infection in Patients Receiving Biologic Therapy for Dermatologic Disorders
Kosche, C. A., Ali, Y., Figueiredo, A. C., West, D. P. & Nardone, B., Sep 15 2019, In: Current Dermatology Reports. 8, 3, p. 141-148 8 p.Research output: Contribution to journal › Review article › peer-review